Spotlight On... GE signs preliminary deal to sell medical devices in Cuba; Varian launches tiny transponder for soft tissue radiation; AFib associated with lower cognitive function; and more...

President Barack Obama's historic visit to Cuba signals improving relations with the island nation--and opportunities for U.S. businesses to sell products there, such as medical devices. GE ($GE) signed a memorandum of understanding with the Cuban government to explore opportunities to equip the country with its medical device offerings, as well as power and aviation infrastructure. A similar deal with Tehran could be next thanks the removal of international sanctions on Iran. More

@FierceMedDev: ICYMI yesterday: Theranos gets the boot as host for Clinton campaign fundraiser. Article | Follow @FierceMedDev

@VarunSaxena2: ICYMI: Med tech consultant discusses China FDA, tries to clear up Chinese clinical trial confusion. Article | Follow @VarunSaxena2

@EmilyWFierce: ICYMI: Embark Veterinary launches DNA testing kit for dogs with research applications in mind. FierceAnimalHealth story | Follow @EmilyWFierce

> Varian Medical Systems ($VAR) has launched a new, tiny Calypso Beacon Transponder to guide radiation therapy in soft tissue tumors that is smaller than a grain of rice. More

> Shockingly, researchers have found that wearable fitness trackers aren't particularly accurate when it comes to calorie counts. Story

> iRhythm Technologies published data in the Journal of the American College of Cardiology showing that a high burden of atrial fibrillation is associated with lower cognitive function. More

Biotech News

@FierceBiotech: Duchenne docs--AKA Sarepta investigators, advisers and advocates--back controversial case for eteplirsen. Article | Follow @FierceBiotech

@JohnCFierce: J&J joins up with Genentech for a pair of atezo/Darzalex combo cancer studies. News | Follow @JohnCFierce

> Pfizer joins next-gen vaccines R&D consortium. Item

> J&J joins up with Genentech for a pair of atezo/Darzalex combo cancer studies. Article

> Fledging biotech Syntimmune gains $10M tranche from its Series A nest egg. Report

> Will Eli Lilly's 11th-hour regulatory gambit salvage or sink its Alzheimer's drug? Editor's corner

Pharma News

@FiercePharma: Humor or fear? Merck uses both to promote shingles shot Zostavax. FiercePharmaMarketing story | Follow @FiercePharma

@CarlyHFierce: Switching study gives Celltrion biosim more ammo in fight for Remicade share. More from FiercePharmaMarketing | Follow @CarlyHFierce

> Novartis CEO Jimenez sees pay drop to $11.9M on Alcon, emerging markets shortfalls. Story

> Could a Bausch & Lomb IPO help save debt-laden Valeant? Ackman thinks so. More

> Amgen's PCSK9 patent win 'reasonably likely' to push Sanofi's Praluent off the market: Analyst. Report

> Anthem sues Express Scripts over drug pricing, considers calling it quits on the PBM. Article

Drug Delivery News

> S. Korean diabetes patch monitors blood sugar and delivers metformin. More

> GSK partnering with Germany's Miltenyi Biotec on cell and gene therapy R&D. Report

> Halozyme initiates Phase III trial of its internal pancreatic cancer candidate. Story

> 'Backpacks' on white blood cells could deliver cancer drugs in a targeted fashion. Article

> Inovio acquires needle-free jet injector tech from Bioject for $5.5M. News

Pharma Manufacturing News

> WHO suspends manufacturing approval of Indian TB drug maker Svizera. Report

> Hitachi Chemical and PCT ink deal for licensing, manufacturing for cell therapy. News

> Boehringer Ingelheim wins first client for China biologics plan. Story

> China hunts for $88M in vaccines diverted to black market. Item

> Marksans the latest Indian drugmaker cited with noncompliance by European regulators. Article

Pharma Asia News

> India's Svizera Labs suspended as TB drugs supplier to WHO. News

> Diabetes in focus as Lechleiter's Asian tour reaches China. Article

> CANbridge in potential $134M licensing deal with AVEO Oncology drug. Story

> Cancer care triage in Asia shows treatment options gap. More

> China FDA on the hunt for illegally sold vaccines in Shandong. Report

Suggested Articles

Grail published new data showing that its cancer-screening blood test is now able to spot more than 50 types of the disease and across all stages.

Battelle received an emergency go-ahead from the FDA over the weekend to deploy its decontamination system for N95 respirator masks.

The limited supply of ventilators is one of the chief concerns facing hospitals as they prepare for more COVID-19 cases.